SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 56.61-0.6%Nov 6 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: rkrw who wrote (21094)9/1/2006 9:52:33 AM
From: DaveAu  Read Replies (3) of 52153
 
"Azimuth was active yesterday, committed funding for dvax and acus with small-discount shares. Not bad deals for dvax/acus assuming they can keep azimuth from shorting."

I don't know why you'd assume that. These deals always have anti-shorting clauses but Azimuth is an offshore company and the shorting can be done through other related companies to keep to the letter, if not the spirit, of the contract. Doing these kind of deals is a sign of either naivete or desperation.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News